MLL
Moody Lynn & Lieberson’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9M | Buy |
58,077
+822
| +1% | +$366K | 1.49% | 22 |
|
|
2025
Q1 | $27.8M | Buy |
57,255
+32
| +0.1% | +$15.5K | 1.78% | 20 |
|
|
2024
Q4 | $23M | Sell |
57,223
-7,984
| -12% | -$3.22M | 1.41% | 24 |
|
|
2024
Q3 | $30.3M | Buy |
65,207
+8,782
| +16% | +$4.08M | 1.87% | 17 |
|
|
2024
Q2 | $26.4M | Sell |
56,425
-5,547
| -9% | -$2.6M | 1.73% | 17 |
|
|
2024
Q1 | $25.9M | Buy |
61,972
+2,461
| +4% | +$1.03M | 1.74% | 18 |
|
|
2023
Q4 | $24.2M | Sell |
59,511
-10,090
| -14% | -$4.11M | 1.84% | 16 |
|
|
2023
Q3 | $24.2M | Sell |
69,601
-354
| -0.5% | -$123K | 2.07% | 14 |
|
|
2023
Q2 | $24.6M | Buy |
69,955
+1,334
| +2% | +$469K | 1.99% | 14 |
|
|
2023
Q1 | $21.6M | Sell |
68,621
-188
| -0.3% | -$59.2K | 1.94% | 19 |
|
|
2022
Q4 | $19.9M | Buy |
68,809
+19,423
| +39% | +$5.61M | 1.82% | 20 |
|
|
2022
Q3 | $14.3M | Buy |
49,386
+28,484
| +136% | +$8.25M | 1.38% | 28 |
|
|
2022
Q2 | $5.89M | Buy |
20,902
+2,269
| +12% | +$639K | 0.53% | 46 |
|
|
2022
Q1 | $4.86M | Buy |
+18,633
| New | +$4.86M | 0.36% | 60 |
|
|
2020
Q3 | – | Sell |
-14,938
| Closed | -$4.34M | – | 210 |
|
|
2020
Q2 | $4.34M | Sell |
14,938
-10,665
| -42% | -$3.1M | 0.47% | 52 |
|
|
2020
Q1 | $6.09K | Sell |
25,603
-562
| -2% | -$134 | 0.84% | 38 |
|
|
2019
Q4 | $5.73M | Buy |
+26,165
| New | +$5.73M | 0.55% | 54 |
|
|
2018
Q1 | – | Sell |
-23,640
| Closed | -$3.94M | – | 216 |
|
|
2017
Q4 | $3.94M | Buy |
+23,640
| New | +$3.94M | 0.42% | 57 |
|
|
2015
Q1 | – | Sell |
-36,390
| Closed | -$4.32M | – | 205 |
|
|
2014
Q4 | $4.32M | Buy |
+36,390
| New | +$4.32M | 0.62% | 59 |
|